1. Home
  2. UMH vs GKOS Comparison

UMH vs GKOS Comparison

Compare UMH & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMH
  • GKOS
  • Stock Information
  • Founded
  • UMH 1968
  • GKOS 1998
  • Country
  • UMH United States
  • GKOS United States
  • Employees
  • UMH N/A
  • GKOS N/A
  • Industry
  • UMH Real Estate Investment Trusts
  • GKOS Medical/Dental Instruments
  • Sector
  • UMH Real Estate
  • GKOS Health Care
  • Exchange
  • UMH Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • UMH 1.4B
  • GKOS 5.1B
  • IPO Year
  • UMH N/A
  • GKOS 2015
  • Fundamental
  • Price
  • UMH $17.47
  • GKOS $96.63
  • Analyst Decision
  • UMH Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • UMH 3
  • GKOS 13
  • Target Price
  • UMH $21.17
  • GKOS $155.00
  • AVG Volume (30 Days)
  • UMH 502.0K
  • GKOS 1.0M
  • Earning Date
  • UMH 05-01-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • UMH 5.17%
  • GKOS N/A
  • EPS Growth
  • UMH N/A
  • GKOS N/A
  • EPS
  • UMH 0.03
  • GKOS N/A
  • Revenue
  • UMH $240,176,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • UMH $10.24
  • GKOS $27.84
  • Revenue Next Year
  • UMH $8.52
  • GKOS $27.99
  • P/E Ratio
  • UMH $580.00
  • GKOS N/A
  • Revenue Growth
  • UMH 9.11
  • GKOS 21.85
  • 52 Week Low
  • UMH $14.73
  • GKOS $77.91
  • 52 Week High
  • UMH $20.64
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • UMH 48.14
  • GKOS 50.06
  • Support Level
  • UMH $16.84
  • GKOS $87.17
  • Resistance Level
  • UMH $17.58
  • GKOS $98.86
  • Average True Range (ATR)
  • UMH 0.61
  • GKOS 5.59
  • MACD
  • UMH 0.05
  • GKOS 1.78
  • Stochastic Oscillator
  • UMH 80.84
  • GKOS 88.89

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: